Loading…
Co-Diagnostics, Inc. is projected to rise to $3.68 by 2027, a +41% move from its current price of $2.61. CODX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $2.37 | $2.61 | $2.87 | +0.07% |
| Jul 15 | $2.28 | $2.61 | $2.99 | +0.13% |
| Jul 16 | $2.22 | $2.62 | $3.09 | +0.20% |
| Jul 17 | $2.16 | $2.62 | $3.17 | +0.27% |
| Jul 18 | $2.12 | $2.62 | $3.24 | +0.33% |
| Jul 19 | $2.07 | $2.62 | $3.31 | +0.40% |
| Jul 20 | $2.04 | $2.62 | $3.38 | +0.47% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.04 | $2.62 | $3.38 | +0.47% |
| Week 2 | $1.84 | $2.63 | $3.77 | +0.94% |
| Week 3 | $1.71 | $2.65 | $4.10 | +1.41% |
| Week 4 | $1.60 | $2.66 | $4.41 | +1.89% |
| Week 5 | $1.52 | $2.67 | $4.70 | +2.36% |
| Week 6 | $1.45 | $2.68 | $4.98 | +2.84% |
| Week 7 | $1.38 | $2.70 | $5.26 | +3.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.
It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting.
Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
Co-Diagnostics, Inc. (CODX) is a healthcare stock trading at $2.73 per share with a market cap of $10.06M, and it ranks 5049.
The near-term forecast for 2026 shows min $1.28, avg $2.73, max $3.85 with ROI 0 and sentiment NEUTRAL.
In the longer term, the forecast projects bullish momentum, including 2030 with avg $3.71 (min $2.29, max $6.45, ROI 36), 2040 with avg $6.44 (min $2.90, max $14.15, ROI 136), and 2050 with avg $8.48 (min $3.81, max $19.49, ROI 210.5) and bullish sentiment across these horizons.
These figures are estimates and not guarantees.
A major floor 50.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 328.7% above — a clean break opens room to run.
A major ceiling 438.3% above — clearing it would confirm fresh momentum.
Key CODX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CODX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.67 | Sell | $2.70 | Sell |
| MA 10 | $2.85 | Sell | $2.88 | Sell |
| MA 20 | $3.24 | Sell | $3.26 | Sell |
| MA 50 | $3.62 | Sell | $3.44 | Sell |
| MA 100 | $2.84 | Sell | $3.74 | Sell |
| MA 200 | $5.76 | Sell | $5.69 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.26 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -100.33 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | -19.20 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.26 | Sell |
| Awesome (5,34) | -1.84 | Sell |
| Ultimate (7,14,28) | 11.21 | Buy |
| Momentum (10) | -0.44 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 2.54 | Buy |
| ADX (14) | 15.17 | Neutral |
| ATR (14) | 0.31 | Info |
The 30-day technical picture is BEARISH.
RSI14 is 40, with SMA50 at $3.54 and SMA200 at $5.96.
Support is at $2.73 and resistance at $11.19; the 30-day range spans $1.34 to $5.56. Annualized volatility stands at 200%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.28 | $2.61 | $3.62 | 0% | Neutral | |
| $2.67 | $3.68 | $5.49 | +41% | Bullish | |
| $2.83 | $4.14 | $6.57 | +59% | Bullish | |
| $2.42 | $3.73 | $6.22 | +43% | Bullish | |
| $2.23 | $3.60 | $6.26 | +38% | Bullish | |
| $1.73 | $2.93 | $5.26 | +12% | Neutral | |
| $1.86 | $3.28 | $6.08 | +26% | Bullish | |
| $2.71 | $4.98 | $9.49 | +91% | Bullish | |
| $2.41 | $4.61 | $9.00 | +77% | Bullish | |
| $2.29 | $4.55 | $9.09 | +74% | Bullish | |
| $2.77 | $6.16 | $13.53 | +136% | Bullish | |
| $3.59 | $7.98 | $18.36 | +206% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.28 | $2.61 | $3.06 | +0.00% |
| August 2026 | $2.10 | $2.54 | $3.21 | -2.60% |
| September 2026 | $2.26 | $2.77 | $3.57 | +9.11% |
| October 2026 | $2.19 | $2.72 | $3.57 | -1.85% |
| November 2026 | $2.02 | $2.54 | $3.38 | -6.54% |
| December 2026 | $2.12 | $2.68 | $3.62 | +5.48% |
Click any year to see its month-by-month CODX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CODX could reach as high as $3.62, with a base case around $2.61 and support toward $1.28 — roughly 0% from $2.61. A consolidation phase looks the most probable path here.
Expect CODX to range from $2.67 to $5.49 through 2027. The $3.68 average target implies a +41% move from current prices. That is up +41% on the projected 2026 average. Momentum favours further upside here.
The CODX price prediction for 2028 points to an average of $4.14 (low $2.83, high $6.57) — a potential gain of +59% on today's $2.61. Buyers look set to stay in control over this stretch.
In 2029, CODX is projected to trade between $2.42 and $6.22, averaging $3.73 — a potential gain of +43% from today's $2.61. That is -10% versus the projected 2028 average. Momentum favours further upside here.
Co-Diagnostics, Inc.'s 2030 outlook centres on $3.60, within a $2.23 to $6.26 range. That is -3% versus the projected 2029 average. That marks a +38% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, CODX could reach as high as $5.26, with a base case around $2.93 and support toward $1.73 — roughly +12% from $2.61. Price action looks broadly range-bound.
Expect CODX to range from $1.86 to $6.08 through 2032. The $3.28 average target implies a +26% move from current prices. That is up +12% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The CODX price prediction for 2033 points to an average of $4.98 (low $2.71, high $9.49) — a potential gain of +91% on today's $2.61. Momentum favours further upside here.
In 2034, CODX is projected to trade between $2.41 and $9.00, averaging $4.61 — a potential gain of +77% from today's $2.61. That is -7% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
Co-Diagnostics, Inc.'s 2035 outlook centres on $4.55, within a $2.29 to $9.09 range. That is -1% versus the projected 2034 average. That marks a +74% change versus current levels. Momentum favours further upside here.
By 2040, CODX could reach as high as $13.53, with a base case around $6.16 and support toward $2.77 — roughly +136% from $2.61. Buyers look set to stay in control over this stretch.
Expect CODX to range from $3.59 to $18.36 through 2050. The $7.98 average target implies a +206% move from current prices. That is up +30% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CODX today (≈ 383.141762 CODX) could be worth
$3,058.1
+$2,058.1 (+206%) by 2050 · US Dollar
Based on the average projected CODX price of $7.98 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CODXwould be worth at today's price.
$1,000 invested in CODX on Jul 10, 2025 (≈ 132.275133 CODX) would be worth
$345.24
-$654.76 (-65.5%) today · 0.35× · US Dollar
Based on a CODX entry price of $7.56 vs. today's $2.61.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.99 | $872.91 | -12.7% |
| 1 month ago | $4.88 | $534.84 | -46.5% |
| 3 months ago | $1.37 | $1,905.11 | +90.5% |
| 6 months ago | $5.98 | $436.45 | -56.4% |
| 1 year ago | $7.56 | $345.24 | -65.5% |
| All time (5.0y) ago | $224.4 | $11.63 | -98.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CODX forecast.
Our base-case forecast reaches $5.20 around 2040.
Implied market cap at $5.20: $19.16M
From 2027 onward, the average forecast shows a bullish trajectory: 2027 avg $3.83, min $2.78, max $5.72, ROI 40.5, sentiment BULLISH; 2028 avg $4.33, min $2.95, max $6.88, ROI 58.6, sentiment BULLISH; 2029 avg $3.93, min $2.55, max $6.56, ROI 44.1, sentiment BULLISH.
2030 min $2.29, avg $3.71, max $6.45, ROI 36, sentiment BULLISH; 2031 min $1.81, avg $3.07, max $5.51, ROI 12.3, sentiment NEUTRAL; 2032 min $1.98, avg $3.50, max $6.48, ROI 28.2, sentiment BULLISH.
2033 min $2.82, avg $5.18, max $9.86, ROI 89.7, sentiment BULLISH; 2034 min $2.51, avg $4.80, max $9.38, ROI 75.9, sentiment BULLISH; 2035 min $2.42, avg $4.80, max $9.59, ROI 75.8, sentiment BULLISH.
2040 min $2.90, avg $6.44, max $14.15, ROI 136, sentiment BULLISH; 2050 min $3.81, avg $8.48, max $19.49, ROI 210.5, sentiment BULLISH.
Tap a question to reveal the answer.
2030 min $2.29, avg $3.71, max $6.45, ROI 36, sentiment BULLISH.
The forecast shows bullish sentiment in 2027-2035 and in 2040 and 2050 with positive ROI values (e.g., ROI 40.5 in 2027, 58.6 in 2028, 89.7 in 2033, 136 in 2040, 210.5 in 2050). However, 2026 shows ROI 0 and these are estimates, not guarantees.
Yes. The 2040 max is $14.15, which exceeds $10, while 2033 max is $9.86.
Current price is $2.73 and market cap is $10.06M.
2026 min $1.28, avg $2.73, max $3.85; ROI 0; sentiment NEUTRAL.
Co-Diagnostics, Inc. Community Discussion
0Share your Co-Diagnostics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.